- New potential checkpoint inhibitors in cancer therapy2022 | Faculty of Medicine in Hradec Králové
- Radiotherapy and immunotherapy are irreplaceable in the treatment of cancer2020 | Faculty of Medicine in Hradec Králové
- Léčba checkpoint inhibitory anti-PD-1 u starších pacientů2019 | First Faculty of Medicine
- Current possibilities of immunotherapy in the treatment of malignant melanoma2018 | Faculty of Medicine in Hradec Králové
- Principles and mechanisms of side effects of modern immunooncological therapy2022 | First Faculty of Medicine
- Identifying predictors of response to unresectable hepatocellular carcinoma treatment with checkpoint inhibitors remains a challenge for the future2021 | Publication without faculty affiliation
- Treatment of metastatic renal cell carcinoma in higher lines - patients after progression on TKI and immune checkpoint inhibitor2022 | First Faculty of Medicine
- Immunotherapeutic options for treatment of malignant melanoma2019 | First Faculty of Medicine
- Tumor mutation burden - a clinical oncologist's perspective2019 | First Faculty of Medicine
- Gastrointestinal Toxicity of Immunotherapy2020 | First Faculty of Medicine
- Immunotherapy in the treatment of lung cancer2017 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Immunotherapy of Renal Cell Carcinoma2017 | First Faculty of Medicine
- Is anticancer immunotherapy break-trough in lung cancer therapy?2019 | First Faculty of Medicine
- Is anticancer imunotherapy break-trough in lung cancer therapy?2020 | First Faculty of Medicine
- Nemalobuněčný karcinom plic - vzácný nežádoucí účinek léčby nivolumabem2022 | First Faculty of Medicine
- Differential diagnosis of pituitary enlargement2022 | First Faculty of Medicine
- New trends in immunotherapy of melanoma2020 | First Faculty of Medicine
- Current status of immunotherapy in the adjuvant treatment of invasive urothelial carcinoma2023 | Faculty of Medicine in Hradec Králové
- Effect of target therapy with BRAF and MEK inhibitors on the immune system in metastatic melanoma2023 | First Faculty of Medicine
- Combination of nivolumab and relatlimab – a new option in the treatment of malignant melanoma2023 | Faculty of Medicine in Hradec Králové
- Malignant pleural mesothelioma – case report2023 | First Faculty of Medicine
- The main pillars of safe immunotherapy2021 | Faculty of Medicine in Pilsen
- Future of lung cancer treatment2021 | First Faculty of Medicine
- Adjuvant therapy of malignant melanoma: general and practical experience2021 | Faculty of Medicine in Hradec Králové
- Current status of nephrectomy in the treatment of metastatic renal cell carcinoma2023 | Faculty of Medicine in Hradec Králové
- Immunotherapy in the first line treatment of non-small cell lung cancer2020 | Faculty of Medicine in Pilsen
- Mechanisms of resistance in malignant melanoma treated by targeted therapy2020 | First Faculty of Medicine
- Immunotherapy in the treatment of triple negative breast cancer2022 | First Faculty of Medicine
- Current treatment options for renal cell carcinoma and outlook2020 | Publication without faculty affiliation
- Aktuální možnosti léčby metastazujícího triple negativního karcinomu prsu2022 | First Faculty of Medicine